01349.HK
Shanghai Fudan Zhangjiang Bio Pharmaceutical Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 2.61
+3.78%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 12.87x
- P/E 2027E
- 18.21x
- P/E 2028E
- 11.44x
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.08x
- Price / sales
- 3.48x
- Price / cash flow
- 13.94x
Enterprise value
- Enterprise value
- HKD 1.3B
- EV / sales
- 1.66x
- EV / EBITDA
- -11.11x
- EV / EBIT
- -8.51x
- Market cap
- HKD 2.7B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026